◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Kyowa Kirin Co., Ltd. (4151) Financial History

Name: Kyowa Kirin Co., Ltd. (4151) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Kyowa Kirin Co., Ltd. (4151) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Chiyoda, Japan with about 5,173 employees. Its market capitalization is roughly JPY 1.34 trillion. In the fiscal year ended 2025-12-31, 4151 reported JPY 496.8B in revenue and JPY 67.0B in net income.

Kyowa Kirin Co., Ltd. engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

Interactive charts & full statements →

4151 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Total Revenue	JPY 496.8B	JPY 495.6B	JPY 442.2B	JPY 398.4B
Gross Profit	JPY 368.9B	JPY 362.9B	JPY 331.0B	JPY 311.5B
Operating Income (EBIT)	JPY 102.3B	JPY 91.9B	JPY 95.8B	JPY 82.4B
Net Income	JPY 67.0B	JPY 59.9B	JPY 81.2B	JPY 53.6B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4151 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(JPY 30.9B)	(JPY 30.9B)	(JPY 29.0B)	(JPY 25.3B)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4151 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	JPY 1.11T	JPY 1.07T	JPY 1.03T	JPY 939.9B	—
Total Liabilities	JPY 214.5B	JPY 216.6B	JPY 189.5B	JPY 177.1B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4151 viewer.

4151 Metric Deep Dives

Other Companies in Drug Manufacturers - Specialty & Generic

4502 · Takeda Pharmaceutical Company Limited — $8.91 trillion
4507 · Shionogi & Co., Ltd. — $2.42 trillion
4523 · Eisai Co., Ltd. — $1.40 trillion
4506 · Sumitomo Pharma Co., Ltd. — $603 billion
1276 · Jiangsu Hengrui Pharmaceuticals Co.,Ltd — $382 billion
4540 · Tsumura & Co. — $280 billion
4516 · Nippon Shinyaku Co., Ltd. — $242 billion
3692 · Hansoh Pharmaceutical Group Company Limited — $200 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 4125 All “0-9” companies 4171 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.